Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial (2026) Atreya R, Kühbacher T, Vieth M, Jefremow A, Hirschmann S, Waldner M, Fischer S, et al. Journal article Authors’ response to letter to editor—silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis (2026) Atreya R, Neurath M Journal article Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review (2026) Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, et al. Journal article, Review article Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study (2026) Cohen NA, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu MT, Atreya R, et al. Journal article, Review article Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease (2026) Reinisch W, Atreya R, Rieder F, Jairath V, Rimola J, Peyrin-Biroulet L, Tozer P, et al. Journal article, Review article Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease (2026) Orlemann T, Zimmermann D, Hübner H, Atreya R, Bodenschatz J, Noviello D, Vitali F, et al. Journal article Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A (2026) Sergeev M, Meier M, Wohlleben P, Rupprecht L, Kupraszewicz-Hutzler M, Hilgers KF, Hartner A, et al. Journal article Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis (2026) Atreya R, Neurath M Journal article Case Report: Successful anti-TNF antibody therapy in steroid-dependent segmental colitis associated with diverticulosis and concomitant ulcerative colitis (2026) Fousekis F, Siebler J, Rath T, Hartmann A, Neurath M, Vieth M, Atreya R Journal article JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease (2025) Fousekis FS, Jefremow A, Katsanos KH, Neurath M, Atreya R Journal article, Review article